Published in Medical Letter on the CDC and FDA, June 26th, 2005
According to recent research from South Korea, "Previously we reported that a mega-dose of Vitamin C enhanced the initial stage of delayed-type hypersensitivity reaction in BALB/c mice. In this study its effects were further evaluated as follows. Mice were administered vitamin C intraperitoneally at 0.625 mg/day or at 5 mg/day for variable days before, during, or after being sensitized with DNFB. T cells were isolated in each group and examined."
"When stimulated antigen-specifically or non-specifically in vitro, mice showed elevated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.